+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios



Public preferences for vaccination and antiviral medicines under different pandemic flu outbreak scenarios



Bmc Public Health 15: 190



During the 2009-2010 A(H1N1) pandemic, many people did not seek care quickly enough, failed to take a full course of antivirals despite being authorised to receive them, and were not vaccinated. Understanding facilitators and barriers to the uptake of vaccination and antiviral medicines will help inform campaigns in future pandemic influenza outbreaks. Increasing uptake of vaccines and antiviral medicines may need to address a range of drivers of behaviour. The aim was to identify facilitators of and barriers to being vaccinated and taking antiviral medicines in uncertain and severe pandemic influenza scenarios using a theoretical model of behaviour change, COM-B. Focus groups and interviews with 71 members of the public in England who varied in their at-risk status. Participants responded to uncertain and severe scenarios, and to messages giving advice on vaccination and antiviral medicines. Data were thematically analysed using the theoretical framework provided by the COM-B model. Influences on uptake of vaccines and antiviral medicines - capabilities, motivations and opportunities - are part of an inter-related behavioural system and different components influenced each other. An identity of being healthy and immune from infection was invoked to explain feelings of invulnerability and hence a reduced need to be vaccinated, especially during an uncertain scenario. The identity of being a 'healthy person' also included beliefs about avoiding medicine and allowing the body to fight disease 'naturally'. This was given as a reason for using alternative precautionary behaviours to vaccination. This identity could be held by those not at-risk and by those who were clinically at-risk. Promoters and barriers to being vaccinated and taking antiviral medicines are multi-dimensional and communications to promote uptake are likely to be most effective if they address several components of behaviour. The benefit of using the COM-B model is that it is at the core of an approach that can identify effective strategies for behaviour change and communications for the future. Identity beliefs were salient for decisions about vaccination. Communications should confront identity beliefs about being a 'healthy person' who is immune from infection by addressing how vaccination can boost wellbeing and immunity.

(PDF emailed within 0-6 h: $19.90)

Accession: 058661752

Download citation: RISBibTeXText

PMID: 25884522

DOI: 10.1186/s12889-015-1541-8


Related references

Choosing pandemic parameters for pandemic preparedness planning: a comparison of pandemic scenarios prior to and following the influenza A(H1N1) 2009 pandemic. Health Policy 109(1): 52-62, 2013

Low acceptability of A/H1N1 pandemic vaccination in French adult population: did public health policy fuel public dissonance?. Plos One 5(4): E10199, 2011

Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States. Emerging Infectious Diseases 17(9): 1591-1598, 2012

Contact tracing and antiviral prophylaxis in the early stages of a pandemic: the probability of a major outbreak. Mathematical Medicine and Biology 32(3): 331-343, 2016

Twitter Influence on UK Vaccination and Antiviral Uptake during the 2009 H1N1 Pandemic. Frontiers in Public Health 4: 26, 2016

Assessment of intensive vaccination and antiviral treatment in 2009 influenza pandemic in Korea. Osong Public Health and Research Perspectives 6(1): 47-51, 2015

Carbon reduction scenarios for 2050: An explorative analysis of public preferences. Energy Policy 63: 796-808, 2013

Antiviral treatment and vaccination for influenza A(H1N1)pdm09 virus: lessons learned from the pandemic. Enfermedades Infecciosas Y Microbiologia Clinica 30 Suppl 4: 49-53, 2013

Estimated impact of aggressive empirical antiviral treatment in containing an outbreak of pandemic influenza H1N1 in an isolated First Nations community. Influenza and Other Respiratory Viruses 7(6): 1409-1415, 2014

Pandemic influenza vaccination during pregnancy: an investigation of vaccine uptake during the 2009/10 pandemic vaccination campaign in Great Britain. Human Vaccines and Immunotherapeutics 9(4): 917-923, 2014

Vaccination against pandemic influenza A/H1N1 among healthcare workers and reasons for refusing vaccination in Istanbul in last pandemic alert phase. Vaccine 28(35): 5703-5710, 2010

Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: a missed opportunity to increase vaccination uptakes in the general public?. Vaccine 28(15): 2743-2748, 2010

Talking to the public about a pandemic: some applications of the WHO outbreak communication guidelines. Yale Journal of Biology and Medicine 78(5): 373-380, 2006

Voting with their feet Public hospital patient preferences under health care reform scenarios. Journal of Investigative Medicine 43(SUPPL 3): 449A, 1995

Antiviral resistance during the 29 influenza A H1N1 pandemic public health, laboratory, and clinical perspectives. 2012